Pen group | Syringe group | (p value) | |
---|---|---|---|
Age in years (mean ± SD) | 64.43 ± 12.60 | 67.68 ± 5.09 | 0.660 |
Male sex (%) | 37.7 | 33.34 | 0.171 |
Race (%) | |||
Caucasian | 60.6 | 70 | 0.083 |
African-descendant | 6.6 | 13.3 | |
Others | 32.8 | 16.7 | |
Religion (%) | |||
Catolics | 70.4 | 61.7 | 0.161 |
Evangelic | 19.7 | 20.0 | |
Spiritualists | 6.60 | 5.00 | |
Others | 3.30 | 13.3 | |
Family income*(%) | |||
Up to 1 minimum wage | 11.4 | 15 | 0.199 |
1–2 minimum wage | 44.3 | 58.3 | |
Over 2 minimum wages | 44.3 | 26.7 | |
Education level in years (%) | |||
Uneducated or less than 1 year | 8.2 | 11.7 | 0.753 |
1 to 3 years | 16.4 | 13.2 | |
4 to 8 years | 45.9 | 51.7 | |
9 years or more | 29.5 | 23.4 | |
History of smoking (%) | |||
Never smoking | 57.4 | 66.6 | 0.364 |
Current smoking | 1.60 | 3.40 | |
Former | 41.0 | 30.0 | |
Alcohol consumption (%) | |||
Never drinking | 54.1 | 55.0 | 0.999 |
Social considers | 27.9 | 26.7 | |
Alcohol abusers | 1.60 | 1.70 | |
former | 16.4 | 16.6 | |
Diabetic Retinopathya n and (%) | |||
Absent | 32/50 (64.0) | 35/49 (71.4) | 0.536 |
Mild or moderative, non proliferative | 9/50 (18.0) | 8/49 (16.3) | |
Severe, non proliferative | 2/50 (4.00) | −(0.00) | |
Proliferative | 7/50 (14.0) | 6/49 (12.3) | |
Diabetic Nephropathyb n and (%) | |||
Absent | 28/51 (54.9) | 30/59 (50.8) | 0.088 |
Albuminuria increased | 15/51 (29.4) | 21/59 (35.6) | |
Albuminuria greatly increased | 6/51 (11.8) | 8/59 (13.6) | |
Nephrotic albuminuria | 2/51 (3.90) | −(0.00) | |
Presence of diabetic neuropathyb n and (%) | 13/49 (26.5) | 21/53 (39.6) | 0.413 |
Presence of cerebrovascular diseasec n and (%) | 13/58 (22.4) | 5/56 (8.90) | 0.077 |
Presence of ischemic cardiopathyd n and (%) | 17/57 (29.9) | 15/60 (25.0) | 0.353 |
Time of diabetes in years (mean ± SD) | 16.89 ± 9.64 | 17.83 ± 9.45 | 0.589 |
Time using insulin in years (mean ± SD) | 8.89 ± 8,94 | 8.22 ± 8.73 | 0.686 |
Glycated hemoglobin (mean ± SD) | 10.34 ± 1.66 | 9.90 ± 1.25 | 0.103 |
Familial history of type 2 diabetes n and (%) | 47/61 (77.0) | 43/60 (71.7) | 0.537 |
Presence of hypertension n and (%) | 57/61 (93.4) | 53/60 (88.3) | 0.464 |
Number of antihyperglycemic agents (mean ± SD) | 2.8 ± 1.54 | 2.58 ± 1.32 | 0.409 |
Classes of antihyperglycemic agents (mean ± SD) | 1.17 ± 0.49 | 1.47 ± 0.62 | 0.050 |
Time of Hypertension in years (mean ± SD) | 17.07 ± 8.36 | 14.67 ± 8.87 | 0.148 |
Number of used drugs (mean ± SD) | 7.66 ± 2.21 | 7.52 ± 2.38 | 0.721 |
Number of antihypertensives (mean ± SD) | 2.80 ± 1.54 | 2.58 ± 1.32 | 0.409 |
Number of use tablet (mean ± SD) | 12.24 ± 4.73 | 11.62 ± 4.93 | 0.625 |
Insulin dose per kg/day (mean ± SD) | 0.76 ± 0.33 | 0.63 ± 0.39 | 0.056 |
BMI (Kg/m2) (mean ± SD) | 31.35 ± 4.35 | 31.53 ± 5.03 | 0.830 |
Systolic blood pressure in mmHg (mean ± SD) | 139.05 ± 15.62 | 133.46 ± 18.22 | 0.072 |
Diastolic blood pressure in mmHg (mean ± SD) | 79.16 ± 12.37 | 73.72 ± 11.03 | 0.012 |